Thomas Kilian is Chief Operating Officer of JMP Securities’ investment banking department and a Managing Director in its financial services investment banking group. He also served as Chief Financial Officer of JMP Group from July 2004 until April 2010, a period which included the company’s IPO in May 2007.

Thomas has been at JMP since its inception in 1999. While at JMP, Thomas has worked with non-bank financial institutions in the broker-dealer, commercial finance, consumer finance, insurance and mortgage sectors and has completed more than 100 capital raising transactions and strategic advisory assignments. Prior to joining JMP, Thomas was at NationsBanc Montgomery Securities, now Banc of America Securities, in the financial services group, focusing on corporate finance. From 1992 until 1996, Thomas served in Deutsche Bank’s corporate development group in Frankfurt, Germany, focusing on strategic planning and business development.

Thomas holds an MBA from Stanford University and a Master’s degree in industrial engineering from Karlsruhe University, Germany.

Ryan Abbe is a Managing Director and is head of real estate investment banking at JMP Securities. He serves on the firm’s investment banking management committee.

Since joining JMP in 2004, Ryan has concentrated on a range of businesses within the real estate industry, including real estate investment trusts, land developers, homebuilders, and real estate-related technology and services companies. Prior to joining JMP, he was a member of the financial institutions group at Piper Jaffray. During his career, he has executed equity and debt capital raising transactions with total proceeds of more than $30 billion and strategic advisory transactions with a total value exceeding $8 billion. .

Ryan holds a BA from Macalester College.

Shawn Cross is a Managing Director and is co-head of healthcare investment banking at JMP Securities. He serves on the firm’s investment banking management committee.

Prior to joining JMP Securities, Shawn was Chairman and Chief Executive Officer of GT Biopharma, a clinical-stage immuno-oncology company. Shawn was previously a Managing Director in healthcare investment banking at Deutsche Bank Securities, where he led the biotechnology coverage effort, after working as a Managing Director and head of biopharmaceutical investment banking at Well Fargo Securities. Earlier, Shawn served in healthcare investment banking roles at Thomas Weisel Partners and Alex. Brown & Sons. Before commencing his Wall Street career, he performed cell cycle cancer research in the division of gastroenterology at University of Washington Medical School.

Shawn holds an MBA in finance from Columbia Business School and a BS in kinesiology from University of California, Los Angeles.

Jon Dever is a Managing Director and is head of financial services investment banking at JMP Securities. He serves on the firm’s investment banking management committee.

Prior to joining JMP, Jon was a Managing Director in the investment banking division at Lehman Brothers, working with finance companies and depositories. Jon previously served as an Executive Director in the financial services group at UBS and spent eight years in investment banking at PaineWebber before its acquisition by UBS in 2000. During his career, he has worked with banks, thrifts and non-bank financial institutions, including mortgage lenders, consumer finance companies, commercial finance companies and specialty lenders such as business development companies and REITs.

Jon holds a BA from Georgetown University.

David Kellman is a Managing Director and is co-head of healthcare investment banking at JMP Securities. He serves on the firm’s investment banking management committee.

Prior to joining JMP Securities, David was a Vice President at Paramount BioSciences, a life sciences investment firm. Previously, he was a hedge fund analyst at S.A.C. Capital Advisors focused on healthcare investing and a member of the healthcare investment banking group at Piper Jaffray. David began his career in the healthcare group of Investor Growth Capital, the venture capital arm of Investor AB.

David holds a BS in finance from the University of Pennsylvania’s Wharton School and a BSE in bioengineering from its School of Engineering and Applied Science.

Kevin McClelland is a Managing Director and is head of technology investment banking at JMP Securities. He serves on the firm’s investment banking management committee.

Prior to joining JMP, Kevin was Principal at Broadview International, a technology-focused M&A advisory firm, where he led the firm’s west coast infrastructure software M&A practice and completed more than 30 transactions, including buy-side and sell-side advisory engagements, divestitures, private placements and strategic advisory assignments. Kevin previously worked for Andersen Consulting, now Accenture, designing and implementing custom and off-the-shelf software applications.

Kevin holds an MBA from Harvard Business School, a BS in electrical engineering from the University of Illinois and a BA from Wheaton College.

Gavin Slader is a Managing Director and is head of mergers and acquisitions at JMP Securities. He serves on the firm’s investment banking management committee.

Prior to joining JMP, Gavin was a senior banker in the technology, media and telecommunications investment banking group at UBS Investment Bank, sharing oversight of the west coast technology mergers and acquisitions practice.  Gavin previously held investment banking roles at Credit Suisse First Boston and its predecessor, Donaldson, Lufkin & Jenrette, concentrating on technology mergers and acquisitions throughout.  He began his Wall Street career in Deutsche Bank’s leveraged finance group.

Gavin holds a BA from Claremont McKenna College, graduating with dual degrees in economics and accounting.

J.J. Brown is a Managing Director and is head of healthcare services investment banking at JMP Securities.

Prior to joining JMP, J.J. was a Director in the healthcare investment banking group at BMO Capital Markets with a focus on the healthcare services sector. Beforehand, he was a Vice President at Brown Brothers Harriman & Co. in the mergers and acquisitions advisory group and an attorney at Skadden Arps, Slate, Meagher & Flom LLP, where he worked in both the corporate finance and mergers and acquisitions departments.

J.J. holds a JD from the New York University School of Law and a BA from Georgetown University.

Tosh Chandra is a Managing Director in JMP Securities’ financial services investment banking group and has focused on commercial and mortgage finance since joining JMP in 2008.

Prior to joining JMP, Tosh was a proprietary market maker for Gotham Investment Management in Gold Options on the COMEX division of the NYMEX. He was previously a Venture Capital Associate at Riverside Management Group and began his career at PaineWebber Incorporated as an Analyst and Associate in the financial institutions group of the Investment Banking Division.

Tosh holds an MBA from the McDonough School of Business at Georgetown University and a BA from Duke University.

Ken Clausman is a Managing Director in the equity capital markets group at JMP Securities.

Prior to joining JMP, Ken was a Director in equity capital markets at Cowen and Company, where he concentrated on the origination and execution of transactions in the life sciences and technology sectors. He previously served in investment banking roles at Cantor Fitzgerald & Co., Waller Capital Partners and Veronis Suhler Stevenson Partners.

Ken holds a BBA from Loyola University Maryland.

Bard Cook is a Managing Director and is Head of Debt Markets and Advisory at JMP Securities.

Bard has 30 years of experience assisting corporate issuers in accessing the capital markets for a wide range of debt instruments including public/Rule 144A investment grade and high yield bonds, hybrid capital securities, private senior and subordinated notes, institutional leveraged loans, syndicated and club lending facilities and asset backed securities. Before joining JMP in 2009, Bard was a Managing Director at RBC Capital Markets, where he established its U.S. corporate debt business and during his tenure was responsible for the firm’s high yield, private placement and investment grade debt capital markets groups. Prior to joining RBC, Bard ran Mellon Bank’s placement division and held several positions in corporate banking.

Bard holds a BA from Yale University.

Carin Fradin is a Managing Director and is head of medical devices and diagnostics investment banking at JMP Securities.

Prior to joining JMP Securities, Carin was a managing director at Four Oaks Partners, a transaction advisory firm serving the life sciences industry, where she focused on the medical device space. She was previously a managing director and senior advisor at boutique investment bank Sagent Advisors. Carin also spent 12 years in healthcare investment banking at UBS Investment Bank, most recently as a managing director, concentrating on the medical device and medical technology industries. For approximately half of her tenure at the firm, Carin additionally led the U.S. execution of all cross-border medical technology transactions originated in Asia.

Carin holds a BA in mathematics and psychology from the University of Pennsylvania.

Forrest Koenig is a Managing Director in JMP Securities’ investment banking group and is Head of Convertible & Equity-Linked Capital Markets.

Prior to joining JMP Securities in 2015, Forrest was a Managing Director in the equity-linked origination group at Piper Jaffray, focusing on the origination and structuring of convertible and equity-linked securities offerings for eight years. Forrest started at Piper Jaffray in 2004 as a quantitative risk analyst on the convertible sales and trading desk, where he concentrated on valuation, modeling and credit analysis. He began his Wall Street career at Citigroup Smith Barney.

Forrest holds a BA in economics with minors in math and physics from the University of California, San Diego. He is a chartered financial analyst.

Andy Mertz is a Managing Director and head of equity capital markets at JMP Securities.

Prior to joining JMP, Andy was a Managing Director in equity capital markets at Cowen and Company, where he oversaw equity financing activity in the technology and healthcare verticals and, earlier in his career, served as head of equity syndicate.  He previously held equity capital markets positions at Robertson Stephens and Bear, Stearns & Co.

Andy holds an MBA from Fordham University and a BBA from Pace University.

Jay Magee is a Managing Director in JMP Securities’ financial services investment banking group. His areas of focus include auto, consumer, commercial and mortgage finance as well as technology-enabled financial services.

Jay joined JMP in July 2005 and has since completed more than 90 middle-market transactions—including public debt and equity financings, private placements and strategic advisory assignments—with an aggregate consideration of nearly $19 billion. Prior to joining JMP, Jay worked in the real estate merchant banking group at Wells Fargo and in the private client group at Merrill Lynch.

Jay holds an MBA from the McDonough School of Business at Georgetown University and a BA from Villanova University.

Don More is a Managing Director in JMP Securities’ technology investment banking group with a focus on cyber security.

Prior to joining JMP Securities, Don was a Managing Director at advisory boutique Signal Hill, where he led the cyber security M&A and financing practice.  He was previously a Managing Director at Updata Capital, concentrating on cyber security and Internet commerce.  Don began his Wall Street career at Merrill Lynch & Co.

Don holds a JD from Columbia University School of Law and a BA from Yale University.

Zeke Navar is a Managing Director in JMP Securities’ healthcare investment banking group.

Prior to joining JMP, Zeke was a Managing Director and Head of Healthcare IT & Services at H2C Securities, executing M&A, equity and debt transactions. He previously served as a Director and Head of Healthcare IT & Services at GCA Savvian Advisors and as a Principal and Co-Head of Healthcare IT at Covington Associates, focusing on mergers and acquisitions. Zeke has also held investment banking roles at Broadview International and Deutsche Banc Alex. Brown. He began his career as a project engineer at General Electric Corporation.

Zeke holds an MBA from the Wharton School of the University of Pennsylvania and a BS in mechanical engineering from the University of Maryland.

David Schechner is a Managing Director in JMP Securities’ healthcare investment banking group.

Prior to joining JMP, David led biotechnology, pharmaceutical, and pharmaceutical services investment banking at Robert W. Baird & Co. He was previously head of the pharmaceuticals investment banking group at Canaccord Genuity, after founding and leading the biotechnology investment banking group at Needham & Company. He also held senior investment banking roles at Goldman Sachs and Bear Stearns, focusing on healthcare and technology.

David holds an MBA from Harvard Business School and a BA from Cornell University.

Jorge Solares-Parkhurst is a Managing Director in JMP Securities’ financial services investment banking group.

Prior to joining JMP, Jorge had been a Director in the global financial institutions group at Credit Suisse, where he worked with U.S. specialty lenders and regional banks. He previously served as a Managing Director at FBR Capital Markets and a Senior Managing Director at Bear, Stearns & Co. Jorge began his career in PaineWebber’s investment banking division, remaining with the firm following its acquisition by UBS and concluding his tenure there as a Director in the financial institutions group for the Americas.

Jorge holds a BSFS in international economics from The Edmund A. Walsh School of Foreign Service at Georgetown University.

Alan Tekerlek is a Managing Director in JMP Securities’ technology investment banking group.

Prior to joining JMP Securities, Alan founded and was managing partner of Aspect Partners, a boutique merchant banking firm focused on advising and investing in middle-market companies in a broad range of industries.  He was previously a senior member of the Global Technology Group at Lehman Brothers, where he provided capital markets and strategic advisory services to corporate clients in the software and Internet and digital media sectors, among others.  Earlier in his career, Alan worked in corporate finance and restructuring at GE Capital Corporation and in strategy consulting at Theodore Barry & Associates.

Alan holds a BA from University of California, Los Angeles.